Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,400 | 1 | 53.2% |
| Food and Beverage | $948.40 | 19 | 21.0% |
| Travel and Lodging | $900.14 | 3 | 20.0% |
| Education | $260.55 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,483 | 6 | $0 (2018) |
| Gilead Sciences, Inc. | $518.20 | 10 | $0 (2019) |
| Chiesi USA, Inc. | $375.52 | 4 | $0 (2017) |
| Cook Incorporated | $47.62 | 1 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $31.70 | 1 | $0 (2017) |
| Allergan Inc. | $29.55 | 2 | $0 (2019) |
| AbbVie, Inc. | $23.22 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $171.44 | 4 | Gilead Sciences, Inc. ($152.89) |
| 2018 | $2,695 | 7 | Genentech USA, Inc. ($2,400) |
| 2017 | $1,642 | 14 | Genentech USA, Inc. ($1,083) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.76 | General |
| 12/03/2019 | Gilead Sciences, Inc. | Cayston (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: RESP | ||||||
| 06/14/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/21/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.18 | General |
| 10/19/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $123.92 | General |
| 09/11/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.84 | General |
| 09/05/2018 | Cook Incorporated | — | Food and Beverage | Cash or cash equivalent | $47.62 | General |
| 05/10/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $55.82 | General |
| 03/30/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Endocrinology | ||||||
| 02/28/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 01/04/2018 | Genentech USA, Inc. | Pulmozyme (Biological) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Virology & Specialty Care | ||||||
| 12/01/2017 | Genentech USA, Inc. | Pulmozyme (Biological) | Food and Beverage | In-kind items and services | $122.23 | General |
| Category: Virology & Specialty Care | ||||||
| 11/03/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $107.18 | General |
| 10/22/2017 | Chiesi USA, Inc. | PERTZYE (Drug) | Education | Cash or cash equivalent | $245.45 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/06/2017 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 07/20/2017 | Chiesi USA, Inc. | PERTZYE (Drug) | Education | Cash or cash equivalent | $15.10 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 04/20/2017 | Chiesi USA, Inc. | BETHKIS (Drug) | Food and Beverage | Cash or cash equivalent | $87.30 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 04/20/2017 | Chiesi USA, Inc. | BETHKIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.67 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/02/2017 | Gilead Sciences Inc | Zydelig (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: ONC | ||||||
| 02/01/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 01/25/2017 | Genentech USA, Inc. | — | Travel and Lodging | In-kind items and services | $588.14 | General |
| 01/25/2017 | Genentech USA, Inc. | — | Travel and Lodging | In-kind items and services | $288.00 | General |
| 01/25/2017 | Genentech USA, Inc. | — | Food and Beverage | Cash or cash equivalent | $60.91 | General |
| 01/25/2017 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| 01/17/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $4.43 | General |
About Dr. Marlyn Woo, MD
Dr. Marlyn Woo, MD is a Pediatric Pulmonology healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477651842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlyn Woo, MD has received a total of $4,509 in payments from pharmaceutical and medical device companies, with $171.44 received in 2019. These payments were reported across 25 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($2,400).
Practice Information
- Specialty Pediatric Pulmonology
- Location West Hollywood, CA
- Active Since 09/20/2006
- Last Updated 11/30/2021
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1477651842
Products in Payments
- Pulmozyme (Biological) $2,522
- PERTZYE (Drug) $260.55
- Cayston (Drug) $124.95
- BETHKIS (Drug) $114.97
- NIOX VERO DEVICE (Device) $31.70
- ZENPEP (Drug) $29.55
- Zydelig (Drug) $29.06
- Creon (Drug) $23.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.